Heartburn News and Research

RSS

Heartburn, also know as acid reflux, is a painful and burning sensation in the esophagus, just behind the breastbone usually associated with regurgitation of gastric acid (gastric reflux).

Drinking wine may lower risk of Barrett's esophagus

Drinking one glass of wine a day may lower the risk of Barrett's Esophagus by 56 percent, according to a new study by the Kaiser Permanente Division of Research in the March issue of Gastroenterology.

2 Mar 2009

Magnetic device studied as treatment for heartburn and acid reflux

More than 20 million Americans suffer from gastroesophageal reflux disease (GERD), experienced by many as chronic heartburn.

23 Feb 2009

Nothing silent about the way ovarian cancer kills

A new study by Australian scientists has revealed that far from being a silent killer, most women diagnosed with ovarian cancer had one or two unusual and persistent symptoms before they were diagnosed.

3 Feb 2009

Non-surgical, non-pharmacological treatments for gastroesophageal reflux disease compared

Two non-surgical, non-pharmacological treatments for gastroesophageal reflux disease (GERD) both appear effective in reducing medication use and improving voice and swallowing symptoms, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.

19 Jan 2009

Chronic gastrointestinal symptoms in Korean population

Chronic gastrointestinal symptoms are highly prevalent in different geographic populations and cause various gastrointestinal symptoms that greatly inconvenience the lives of those affected.

30 Dec 2008

AstraZeneca submits sNDA for NEXIUM (esomeprazole magnesium)

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for NEXIUM(R) (esomeprazole magnesium) to seek approval for the short-term (up to 6 weeks) treatment of gastroesophageal reflux disease (GERD) in pediatric patients ages 0 to 1 year old.

21 Dec 2008

Changes in medical terminology confuses patients

The label used to identify a disease - whether it is common language or medical terminology - can influence how serious people think the condition is, according to new research from McMaster University, the second part of a larger study on how people understand and interpret disease.

8 Dec 2008

Horizon Therapeutics announces HZT-501 trials meet primary endpoints

Horizon Therapeutics, Inc. has announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT 501, met all primary endpoints.

3 Dec 2008

Reminder, signs of a heart attack can be subtle

You know the drill: join the family for feasting on a high-fat, carbohydrate-filled meal followed by a generous slice of pumpkin pie

21 Nov 2008

Five key proteins form new, early-warning blood test before heart attack strikes

A team of Johns Hopkins biochemists has identified a mixed bag of five key proteins out of thousands secreted into blood draining from the heart's blood vessels that may together or in certain quantities form the basis of a far more accurate early warning test than currently in use of impending heart attack in people with severely reduced blood flow, or ischemia.

10 Nov 2008

Too many women ignorant of symptoms of ovarian cancer

A new survey had revealed that though ovarian cancer remains one of biggest gynaecological cancer killers, many women are unsure or unaware of the symptoms of the disease.

10 Aug 2008

New therapy freezes out esophagus cancer

UT Southwestern Medical Center gastroenterologists are using a new method to freeze damaged cells in the esophagus, preventing them from turning cancerous.

29 Jul 2008

Patent for Aciphex ruled valid and enforceable

PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today that the U.S. Federal Circuit Court of Appeals affirmed the judgments of the United States District Court for the Southern District of New York that the patent for Aciphex (rabeprazole sodium 20 mg tablets) is valid and enforceable.

21 Jul 2008

Hurried doctor visits can leave patients bewildered

Have you ever been whisked through a doctor's visit, and afterward were unable to remember what the doctor said? A University of Rochester Medical Center study disclosed that doctors don't often take the steps necessary to help patients recall medical instructions.

26 Jun 2008

Walgreen agrees to pay $35 million to settle allegations of improper medication switches for Medicaid beneficiaries

Walgreen has agreed to pay $35 million to settle allegations that the company improperly switched the form of generic medications prescribed to Medicaid beneficiaries to receive higher reimbursements from the program, the Hartford Courant reports (Levick, Hartford Courant, 6/5).

8 Jun 2008

A magnetically contolled camera pill

Images from inside the body? It can be done with tiny cameras which the patient has to swallow. In the past there was no way of controlling the device as it passed through the body. Now it can be steered and stopped where desired, and even deliver images of the esophagus.

3 Jun 2008

FDA approves Entereg (alvimopan) to restore bowel function

The U.S. Food and Drug Administration approved Entereg (alvimopan) today to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery. Entereg will be used in hospitalized patients who can receive no more than 15 doses.

20 May 2008

Physician Gainsharing programs reduce hospital spending

Giving physicians cash payments for reduced hospital spending can help control costs without sacrificing quality or access to care, researchers report in a study released today in the May/June 2008 issue of the journal Health Affairs. The issue is a thematic volume on health reform supported by a grant from the Robert Wood Johnson Foundation.

13 May 2008

FDA grants priority review for ACIPHEX (rabeprazole sodium) sNDA for treatment of GERD in adolescents

Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., has announced that the Food and Drug Administration (FDA) has accepted an ACIPHEX supplemental New Drug Application (sNDA) for the short-term (up to eight weeks) treatment of gastroesophageal reflux disease (GERD) in patients ages 12-16.

3 Mar 2008